Monika Mielcarek‐Siedziuk

Higher CD34+ and CD3+ Cell Doses in the Graft Promote Long-Term Survival, and Have No Impact on the Incidence of Severe Acute or Chronic Graft-versus-Host Disease after In Vivo T Cell-Depleted Unrelated Donor Hematopoietic Stem Cell Transplantation in Children

Krzysztof Kałwak, Julita Porwolik, Monika Mielcarek‐Siedziuk et al. · Biology of Blood and Marrow Transplantation · 2010 · 74 citations · Full text

Life Sciences, Hematology, Immunology +17

Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies

Krzysztof Kałwak, Monika Mielcarek‐Siedziuk, Katharine Patrick et al. · Bone Marrow Transplantation · 2020 · 34 citations · Full text

Medicine, Hematology, Pediatrics +16

Immune recovery and the risk of CMV/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation

Małgorzata Janeczko, Monika Mielcarek‐Siedziuk, Blanka Rybka et al. · Central European Journal of Immunology · 2016 · 27 citations · Full text

Life Sciences, Immunology, Pediatrics +15

Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting?

Zofia Szmit, Ewa Gorczyńska, Anna Król et al. · Bone Marrow Transplantation · 2020 · 25 citations

Medicine, Child Health, Pediatrics +3

Allogeneic Stem Cell Transplantation after Fanconi Anemia Conditioning in Children with Ataxia-Telangiectasia Results in Stable T Cell Engraftment and Lack of Infections despite Mixed Chimerism

Marek Ussowicz, Elżbieta Wawrzyniak-Dzierżek, Monika Mielcarek‐Siedziuk et al. · Biology of Blood and Marrow Transplantation · 2018 · 21 citations · Full text

Medicine, Hematology, Immunology +16